| 0 |
BLOOD CATECHOLAMINES |
1 |
0.5000 |
| 1 |
NEUROENDOCRINE TUMOUR OF THE RECTUM |
12 |
0.3750 |
| 2 |
NEUROENDOCRINE TUMOUR METASTATIC |
3 |
0.3333 |
| 3 |
SMALL INTESTINE NEUROENDOCRINE TUMOUR |
18 |
0.3273 |
| 4 |
GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOUR DISEASE |
27 |
0.2432 |
| 5 |
ACTH-PRODUCING PITUITARY TUMOUR |
2 |
0.1538 |
| 6 |
CARCINOID HEART DISEASE |
13 |
0.1429 |
| 7 |
ANAPLASTIC MENINGIOMA |
4 |
0.1379 |
| 8 |
CARCINOID CRISIS |
30 |
0.1327 |
| 9 |
PANCREATIC NEUROENDOCRINE TUMOUR |
78 |
0.1217 |
| 10 |
PANCREATIC NEUROENDOCRINE TUMOUR METASTATIC |
23 |
0.0962 |
| 11 |
CARCINOID TUMOUR OF THE LIVER |
2 |
0.0833 |
| 12 |
NEUROENDOCRINE TUMOUR |
103 |
0.0727 |
| 13 |
GASTROINTESTINAL NEUROENDOCRINE CARCINOMA |
2 |
0.0690 |
| 14 |
CARCINOID SYNDROME |
23 |
0.0635 |
| 15 |
PARAGANGLION NEOPLASM |
9 |
0.0616 |
| 16 |
GASTROINTESTINAL NEUROENDOCRINE TUMOUR |
4 |
0.0615 |
| 17 |
5-HYDROXYINDOLACETIC ACID IN URINE |
1 |
0.0588 |
| 18 |
NEUROENDOCRINE TUMOUR OF THE LUNG METASTATIC |
3 |
0.0556 |
| 19 |
BENIGN NEOPLASM OF EYELID |
1 |
0.0556 |
| 20 |
HEPATIC NEUROENDOCRINE TUMOUR |
2 |
0.0541 |
| 21 |
CATECHOLAMINE CRISIS |
2 |
0.0541 |
| 22 |
CARCINOID TUMOUR IN THE LARGE INTESTINE |
1 |
0.0526 |
| 23 |
CARCINOID TUMOUR OF THE DUODENUM |
1 |
0.0476 |
| 24 |
NEUROENDOCRINE TUMOUR OF THE LUNG |
5 |
0.0463 |
| 25 |
INSULINOMA |
8 |
0.0452 |
| 26 |
AESTHESIONEUROBLASTOMA |
1 |
0.0435 |
| 27 |
METASTATIC CARCINOID TUMOUR |
4 |
0.0385 |
| 28 |
BLOOD CHROMOGRANIN A INCREASED |
17 |
0.0370 |
| 29 |
PCO2 ABNORMAL |
2 |
0.0345 |
| 30 |
NEUROENDOCRINE CARCINOMA METASTATIC |
8 |
0.0325 |
| 31 |
5-HYDROXYINDOLACETIC ACID INCREASED |
2 |
0.0308 |
| 32 |
ILL-DEFINED DISORDER |
1542 |
0.0254 |
| 33 |
EXPOSURE TO RADIATION |
3 |
0.0238 |
| 34 |
BLOOD GASTRIN INCREASED |
3 |
0.0234 |
| 35 |
ENDOCRINE PANCREATIC DISORDER |
1 |
0.0233 |
| 36 |
BASE EXCESS INCREASED |
2 |
0.0225 |
| 37 |
SARS-COV-2 TEST |
2 |
0.0211 |
| 38 |
BENIGN LYMPH NODE NEOPLASM |
2 |
0.0204 |
| 39 |
CARCINOID TUMOUR OF THE APPENDIX |
1 |
0.0185 |
| 40 |
ACUTE OESOPHAGEAL MUCOSAL LESION |
1 |
0.0182 |
| 41 |
5-HYDROXYINDOLACETIC ACID IN URINE INCREASED |
1 |
0.0182 |
| 42 |
CARCINOID TUMOUR OF THE GASTROINTESTINAL TRACT |
2 |
0.0168 |
| 43 |
MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS |
2 |
0.0164 |
| 44 |
METASTASES TO PANCREAS |
7 |
0.0158 |
| 45 |
NEUROENDOCRINE CARCINOMA |
10 |
0.0145 |
| 46 |
PORTAL VEIN OCCLUSION |
2 |
0.0137 |
| 47 |
METASTASES TO STOMACH |
5 |
0.0128 |
| 48 |
PITUITARY APOPLEXY |
2 |
0.0114 |
| 49 |
MONOCYTE PERCENTAGE INCREASED |
8 |
0.0113 |
| 50 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1294 |
0.0112 |
| 51 |
BLOOD CORTICOTROPHIN INCREASED |
3 |
0.0104 |
| 52 |
AMINO ACID LEVEL ABNORMAL |
1 |
0.0103 |
| 53 |
METASTASES TO HEART |
3 |
0.0099 |
| 54 |
CARCINOID TUMOUR OF THE SMALL BOWEL |
1 |
0.0096 |
| 55 |
TUMOUR NECROSIS |
10 |
0.0095 |
| 56 |
MARGINAL ZONE LYMPHOMA |
2 |
0.0093 |
| 57 |
METASTASES TO BREAST |
3 |
0.0090 |
| 58 |
CEREBROSPINAL FLUID RETENTION |
1 |
0.0085 |
| 59 |
BONE MARROW TUMOUR CELL INFILTRATION |
1 |
0.0085 |
| 60 |
MALIGNANT PERITONEAL NEOPLASM |
5 |
0.0085 |
| 61 |
SERUM SEROTONIN INCREASED |
3 |
0.0085 |
| 62 |
NEUROGENIC BOWEL |
2 |
0.0084 |
| 63 |
CARCINOID TUMOUR PULMONARY |
2 |
0.0083 |
| 64 |
INTESTINAL METASTASIS |
3 |
0.0083 |
| 65 |
ABDOMINAL WALL MASS |
1 |
0.0082 |
| 66 |
CARCINOID TUMOUR |
6 |
0.0081 |
| 67 |
BED BUG INFESTATION |
1 |
0.0079 |
| 68 |
BONE MARROW INFILTRATION |
3 |
0.0078 |
| 69 |
HYPERPROTEINAEMIA |
2 |
0.0076 |
| 70 |
EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS ABNORMAL |
1 |
0.0075 |
| 71 |
HAEMORRHAGIC ASCITES |
2 |
0.0070 |
| 72 |
HEPATIC CANCER METASTATIC |
6 |
0.0070 |
| 73 |
PSYCHOSEXUAL DISORDER |
2 |
0.0069 |
| 74 |
DUODENAL OBSTRUCTION |
2 |
0.0067 |
| 75 |
CHONDROSARCOMA |
1 |
0.0063 |
| 76 |
HAEMATOLOGY TEST ABNORMAL |
2 |
0.0062 |
| 77 |
LYMPHOCYTE PERCENTAGE DECREASED |
8 |
0.0060 |
| 78 |
LABORATORY TEST ABNORMAL |
174 |
0.0059 |
| 79 |
TUMOUR FLARE |
4 |
0.0059 |
| 80 |
METASTASES TO LIVER |
103 |
0.0059 |
| 81 |
BLOOD OESTROGEN ABNORMAL |
1 |
0.0058 |
| 82 |
ANION GAP DECREASED |
2 |
0.0057 |
| 83 |
LIVER FUNCTION TEST DECREASED |
2 |
0.0056 |
| 84 |
HYPOGLYCAEMIC SEIZURE |
5 |
0.0055 |
| 85 |
BILIARY OBSTRUCTION |
7 |
0.0054 |
| 86 |
BRAIN SCAN ABNORMAL |
3 |
0.0054 |
| 87 |
HEPATIC INFARCTION |
2 |
0.0053 |
| 88 |
ALVEOLAR LUNG DISEASE |
1 |
0.0053 |
| 89 |
BLOOD CHLORIDE INCREASED |
9 |
0.0052 |
| 90 |
HEPATIC LESION |
22 |
0.0051 |
| 91 |
LIVER ABSCESS |
16 |
0.0049 |
| 92 |
SARS-COV-2 TEST POSITIVE |
65 |
0.0049 |
| 93 |
BLOOD BILIRUBIN DECREASED |
3 |
0.0049 |
| 94 |
BENIGN BONE NEOPLASM |
1 |
0.0048 |
| 95 |
PYRAMIDAL TRACT SYNDROME |
2 |
0.0048 |
| 96 |
VAGINAL ULCERATION |
2 |
0.0048 |
| 97 |
METASTASES TO PELVIS |
3 |
0.0047 |
| 98 |
SYSTOLIC HYPERTENSION |
2 |
0.0046 |
| 99 |
PHAEOCHROMOCYTOMA |
3 |
0.0046 |
| 100 |
GALLBLADDER RUPTURE |
2 |
0.0043 |
| 101 |
BLOOD BICARBONATE INCREASED |
2 |
0.0042 |
| 102 |
ALANINE AMINOTRANSFERASE DECREASED |
3 |
0.0041 |
| 103 |
PERFORMANCE STATUS DECREASED |
19 |
0.0041 |
| 104 |
METASTASES TO ABDOMINAL CAVITY |
2 |
0.0041 |
| 105 |
BLOOD UREA DECREASED |
5 |
0.0040 |
| 106 |
HERPES ZOSTER OTICUS |
2 |
0.0039 |
| 107 |
CHROMOSOME ANALYSIS ABNORMAL |
1 |
0.0039 |
| 108 |
VERTEBRAL LESION |
2 |
0.0039 |
| 109 |
DUMPING SYNDROME |
1 |
0.0038 |
| 110 |
RETROPERITONEAL LYMPHADENOPATHY |
2 |
0.0038 |
| 111 |
BONE CANCER METASTATIC |
2 |
0.0038 |
| 112 |
CHOLANGITIS INFECTIVE |
1 |
0.0038 |
| 113 |
EOSINOPHIL PERCENTAGE INCREASED |
2 |
0.0037 |
| 114 |
ENTEROCOLITIS BACTERIAL |
1 |
0.0036 |
| 115 |
BLOOD PH INCREASED |
2 |
0.0036 |
| 116 |
STARVATION |
3 |
0.0036 |
| 117 |
MEAN CELL HAEMOGLOBIN CONCENTRATION INCREASED |
2 |
0.0036 |
| 118 |
MONOCYTE COUNT INCREASED |
13 |
0.0036 |
| 119 |
SUPERFICIAL VEIN THROMBOSIS |
3 |
0.0036 |
| 120 |
MALIGNANT NEOPLASM PROGRESSION |
364 |
0.0036 |
| 121 |
CARDIO-RESPIRATORY DISTRESS |
1 |
0.0035 |
| 122 |
OPHTHALMIC HERPES SIMPLEX |
2 |
0.0035 |
| 123 |
ADNEXA UTERI MASS |
1 |
0.0035 |
| 124 |
CATHETER SITE HAEMATOMA |
1 |
0.0034 |
| 125 |
SECOND PRIMARY MALIGNANCY |
28 |
0.0034 |
| 126 |
PROTHROMBIN TIME RATIO DECREASED |
2 |
0.0032 |
| 127 |
SPIDER VEIN |
2 |
0.0031 |
| 128 |
PYELOCALIECTASIS |
3 |
0.0031 |
| 129 |
ACTIVITIES OF DAILY LIVING DECREASED |
2 |
0.0031 |
| 130 |
METASTASES TO BONE |
50 |
0.0030 |
| 131 |
HEPATIC PAIN |
13 |
0.0030 |
| 132 |
CHRONIC MYELOMONOCYTIC LEUKAEMIA |
2 |
0.0030 |
| 133 |
ADMINISTRATION SITE EXTRAVASATION |
3 |
0.0030 |
| 134 |
ABDOMINAL MASS |
8 |
0.0030 |
| 135 |
METASTASES TO LYMPH NODES |
20 |
0.0030 |
| 136 |
CARBON DIOXIDE INCREASED |
4 |
0.0029 |
| 137 |
METASTASES TO PLEURA |
3 |
0.0029 |
| 138 |
UTERINE PROLAPSE |
3 |
0.0028 |
| 139 |
LYMPHOCYTE COUNT DECREASED |
47 |
0.0027 |
| 140 |
CHOLANGITIS ACUTE |
2 |
0.0026 |
| 141 |
BASOPHIL COUNT INCREASED |
2 |
0.0026 |
| 142 |
MALIGNANT ASCITES |
2 |
0.0026 |
| 143 |
CARBON DIOXIDE DECREASED |
3 |
0.0026 |
| 144 |
MONOCYTE COUNT DECREASED |
3 |
0.0025 |
| 145 |
HORMONE LEVEL ABNORMAL |
12 |
0.0025 |
| 146 |
MEAN CELL HAEMOGLOBIN INCREASED |
4 |
0.0024 |
| 147 |
RED CELL DISTRIBUTION WIDTH INCREASED |
10 |
0.0024 |
| 148 |
MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED |
4 |
0.0024 |
| 149 |
MEAN PLATELET VOLUME DECREASED |
2 |
0.0024 |
| 150 |
METASTASES TO PERITONEUM |
6 |
0.0024 |
| 151 |
INTESTINAL ISCHAEMIA |
13 |
0.0024 |
| 152 |
CANCER PAIN |
6 |
0.0023 |
| 153 |
ABDOMINAL SEPSIS |
2 |
0.0023 |
| 154 |
BLADDER HYPERTROPHY |
1 |
0.0023 |
| 155 |
OBSTRUCTION |
9 |
0.0023 |
| 156 |
BLOOD CREATININE DECREASED |
7 |
0.0022 |
| 157 |
CONGESTIVE HEPATOPATHY |
1 |
0.0022 |
| 158 |
ANASTOMOTIC ULCER |
1 |
0.0022 |
| 159 |
ENCEPHALITIS |
15 |
0.0022 |
| 160 |
PLATELET COUNT DECREASED |
231 |
0.0022 |
| 161 |
CREATININE RENAL CLEARANCE ABNORMAL |
1 |
0.0022 |
| 162 |
BILIARY SEPSIS |
1 |
0.0022 |
| 163 |
TUMOUR LYSIS SYNDROME |
19 |
0.0022 |
| 164 |
BLOOD ALBUMIN DECREASED |
17 |
0.0021 |
| 165 |
PROTHROMBIN TIME SHORTENED |
3 |
0.0021 |
| 166 |
ECZEMA ASTEATOTIC |
1 |
0.0021 |
| 167 |
INVESTIGATION ABNORMAL |
3 |
0.0021 |
| 168 |
BLAST CELLS PRESENT |
1 |
0.0021 |
| 169 |
BLOOD CREATINE ABNORMAL |
1 |
0.0021 |
| 170 |
BLOOD URIC ACID DECREASED |
1 |
0.0021 |
| 171 |
DUODENAL STENOSIS |
1 |
0.0021 |
| 172 |
RED BLOOD CELL COUNT ABNORMAL |
3 |
0.0020 |
| 173 |
ARTERIOVENOUS FISTULA |
1 |
0.0020 |
| 174 |
MYELODYSPLASTIC SYNDROME |
29 |
0.0020 |
| 175 |
CORNEAL SCAR |
1 |
0.0020 |
| 176 |
BLOOD PRESSURE DIASTOLIC INCREASED |
9 |
0.0019 |
| 177 |
BLADDER OBSTRUCTION |
1 |
0.0019 |
| 178 |
EXTRAVASATION |
8 |
0.0019 |
| 179 |
BLOOD CHLORIDE DECREASED |
5 |
0.0019 |
| 180 |
ASCITES |
57 |
0.0019 |
| 181 |
GASTROINTESTINAL PERFORATION |
8 |
0.0019 |
| 182 |
BLOOD SODIUM ABNORMAL |
2 |
0.0019 |
| 183 |
VASCULAR CALCIFICATION |
2 |
0.0019 |
| 184 |
ALBUMINURIA |
1 |
0.0019 |
| 185 |
PANCREATIC MASS |
2 |
0.0019 |
| 186 |
PROTEIN TOTAL DECREASED |
7 |
0.0019 |
| 187 |
ACUTE LEUKAEMIA |
3 |
0.0019 |
| 188 |
OESOPHAGEAL VARICES HAEMORRHAGE |
4 |
0.0018 |
| 189 |
BLADDER DILATATION |
2 |
0.0018 |
| 190 |
CLAUSTROPHOBIA |
2 |
0.0018 |
| 191 |
SMALL INTESTINE CARCINOMA |
4 |
0.0018 |
| 192 |
METASTASES TO SPINE |
6 |
0.0018 |
| 193 |
CONCOMITANT DISEASE AGGRAVATED |
11 |
0.0018 |
| 194 |
CHOLANGITIS |
11 |
0.0018 |
| 195 |
BACTERIURIA |
1 |
0.0018 |
| 196 |
ACUTE MYELOID LEUKAEMIA |
27 |
0.0017 |
| 197 |
RADIATION SKIN INJURY |
2 |
0.0017 |
| 198 |
DILATATION ATRIAL |
2 |
0.0017 |
| 199 |
GLOMERULAR FILTRATION RATE DECREASED |
21 |
0.0017 |
| 200 |
LYMPHOPENIA |
24 |
0.0017 |
| 201 |
HAEMATOTOXICITY |
16 |
0.0017 |
| 202 |
BLEEDING TIME PROLONGED |
2 |
0.0017 |
| 203 |
ILLNESS |
167 |
0.0016 |
| 204 |
BILIARY TRACT INFECTION |
1 |
0.0016 |
| 205 |
HEPATIC NECROSIS |
6 |
0.0016 |
| 206 |
RADIOTHERAPY |
3 |
0.0016 |
| 207 |
BLOOD BILIRUBIN ABNORMAL |
2 |
0.0016 |
| 208 |
ENDOCRINE DISORDER |
2 |
0.0016 |
| 209 |
HEPATIC MASS |
3 |
0.0016 |
| 210 |
CONCOMITANT DISEASE PROGRESSION |
3 |
0.0015 |
| 211 |
ANISOCYTOSIS |
1 |
0.0015 |
| 212 |
CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE |
1 |
0.0015 |
| 213 |
CREATININE RENAL CLEARANCE DECREASED |
6 |
0.0015 |
| 214 |
ANION GAP INCREASED |
2 |
0.0015 |
| 215 |
FULL BLOOD COUNT DECREASED |
30 |
0.0015 |
| 216 |
BODY MASS INDEX INCREASED |
2 |
0.0015 |
| 217 |
DISEASE PROGRESSION |
174 |
0.0015 |
| 218 |
BILIARY TRACT DISORDER |
2 |
0.0014 |
| 219 |
DISCHARGE |
2 |
0.0014 |
| 220 |
SUBILEUS |
3 |
0.0014 |
| 221 |
ANAEMIA MACROCYTIC |
3 |
0.0014 |
| 222 |
HEART VALVE INCOMPETENCE |
4 |
0.0014 |
| 223 |
METASTATIC NEOPLASM |
6 |
0.0014 |
| 224 |
BONE LESION |
5 |
0.0014 |
| 225 |
BITE |
1 |
0.0014 |
| 226 |
DYSLALIA |
1 |
0.0014 |
| 227 |
BLOOD BILIRUBIN UNCONJUGATED INCREASED |
1 |
0.0014 |
| 228 |
FAILURE TO THRIVE |
7 |
0.0013 |
| 229 |
AXILLARY PAIN |
2 |
0.0013 |
| 230 |
GASTROINTESTINAL WALL THICKENING |
2 |
0.0013 |
| 231 |
PLATELET COUNT ABNORMAL |
8 |
0.0013 |
| 232 |
BLOOD UREA INCREASED |
22 |
0.0013 |
| 233 |
COAGULATION TEST ABNORMAL |
1 |
0.0013 |
| 234 |
SMALL INTESTINAL OBSTRUCTION |
16 |
0.0013 |
| 235 |
MEAN CELL VOLUME DECREASED |
2 |
0.0013 |
| 236 |
DISSEMINATED INTRAVASCULAR COAGULATION |
18 |
0.0013 |
| 237 |
ABDOMINAL SYMPTOM |
1 |
0.0012 |
| 238 |
CARTILAGE ATROPHY |
1 |
0.0012 |
| 239 |
CARDIAC VALVE DISEASE |
7 |
0.0012 |
| 240 |
SEBORRHOEIC DERMATITIS |
2 |
0.0012 |
| 241 |
CAMPYLOBACTER INFECTION |
1 |
0.0012 |
| 242 |
NEUTROPHIL COUNT INCREASED |
12 |
0.0012 |
| 243 |
MEAN CELL VOLUME INCREASED |
3 |
0.0012 |
| 244 |
CACHEXIA |
6 |
0.0012 |
| 245 |
PHYSICAL DECONDITIONING |
3 |
0.0012 |
| 246 |
LEUKAEMIA |
11 |
0.0012 |
| 247 |
THROMBOCYTOPENIA |
130 |
0.0012 |
| 248 |
HYPOALBUMINAEMIA |
9 |
0.0012 |
| 249 |
CARDIAC OUTPUT DECREASED |
1 |
0.0011 |
| 250 |
COVID-19 |
198 |
0.0011 |
| 251 |
BLOOD PRESSURE SYSTOLIC INCREASED |
22 |
0.0011 |
| 252 |
PROTEIN TOTAL INCREASED |
3 |
0.0011 |
| 253 |
METASTASES TO LUNG |
13 |
0.0011 |
| 254 |
PRODUCT CONTAMINATION |
4 |
0.0011 |
| 255 |
CYTOMEGALOVIRUS TEST POSITIVE |
2 |
0.0011 |
| 256 |
WHITE BLOOD CELL DISORDER |
3 |
0.0011 |
| 257 |
METASTASIS |
8 |
0.0011 |
| 258 |
BLOOD ALKALINE PHOSPHATASE ABNORMAL |
1 |
0.0011 |
| 259 |
CERUMEN IMPACTION |
1 |
0.0011 |
| 260 |
MEAN CELL HAEMOGLOBIN DECREASED |
2 |
0.0011 |
| 261 |
ANEURYSM RUPTURED |
1 |
0.0011 |
| 262 |
INTESTINAL OBSTRUCTION |
41 |
0.0011 |
| 263 |
ELECTRIC SHOCK SENSATION |
3 |
0.0011 |
| 264 |
DRUG TOLERANCE DECREASED |
3 |
0.0011 |
| 265 |
FLANK PAIN |
10 |
0.0011 |
| 266 |
SMALL INTESTINAL PERFORATION |
2 |
0.0011 |
| 267 |
BLOOD UREA ABNORMAL |
1 |
0.0011 |
| 268 |
BRAIN STEM HAEMORRHAGE |
1 |
0.0011 |
| 269 |
BLOOD BICARBONATE DECREASED |
2 |
0.0011 |
| 270 |
HYPOPROTEINAEMIA |
2 |
0.0011 |
| 271 |
TUMOUR HAEMORRHAGE |
3 |
0.0011 |
| 272 |
TUMOUR MARKER INCREASED |
5 |
0.0010 |
| 273 |
GINGIVAL RECESSION |
2 |
0.0010 |
| 274 |
SPINAL CORD COMPRESSION |
4 |
0.0010 |
| 275 |
BICYTOPENIA |
2 |
0.0010 |
| 276 |
DUODENAL PERFORATION |
1 |
0.0010 |
| 277 |
RED BLOOD CELL COUNT DECREASED |
29 |
0.0010 |
| 278 |
HAEMATOCRIT DECREASED |
20 |
0.0010 |
| 279 |
CELL DEATH |
2 |
0.0010 |
| 280 |
BLOOD TEST ABNORMAL |
14 |
0.0010 |
| 281 |
BONE MARROW DISORDER |
3 |
0.0010 |
| 282 |
HYPOGLYCAEMIA |
48 |
0.0010 |
| 283 |
VITAMIN B12 DEFICIENCY |
4 |
0.0010 |
| 284 |
CHANGE OF BOWEL HABIT |
2 |
0.0010 |
| 285 |
ACUTE PROMYELOCYTIC LEUKAEMIA |
1 |
0.0010 |
| 286 |
CORONAVIRUS TEST POSITIVE |
1 |
0.0010 |
| 287 |
PANCYTOPENIA |
54 |
0.0010 |
| 288 |
AXILLARY MASS |
1 |
0.0010 |
| 289 |
CYTOGENETIC ANALYSIS ABNORMAL |
1 |
0.0010 |
| 290 |
BLOOD PRESSURE DIASTOLIC DECREASED |
7 |
0.0009 |
| 291 |
NEUROGENIC BLADDER |
2 |
0.0009 |
| 292 |
FULL BLOOD COUNT ABNORMAL |
10 |
0.0009 |
| 293 |
POLYMYALGIA RHEUMATICA |
3 |
0.0009 |
| 294 |
ENTERITIS |
6 |
0.0009 |
| 295 |
HYDRONEPHROSIS |
7 |
0.0009 |
| 296 |
BONE NEOPLASM |
1 |
0.0009 |
| 297 |
HEPATIC NEOPLASM |
3 |
0.0009 |
| 298 |
HEPATOMEGALY |
9 |
0.0009 |
| 299 |
AORTIC DILATATION |
1 |
0.0009 |
| 300 |
PROSTATE CANCER METASTATIC |
3 |
0.0009 |
| 301 |
CARDIAC HYPERTROPHY |
1 |
0.0009 |
| 302 |
HEPATIC FAILURE |
27 |
0.0009 |
| 303 |
ADENOCARCINOMA |
2 |
0.0009 |
| 304 |
CYTOGENETIC ABNORMALITY |
1 |
0.0009 |
| 305 |
ILEUS |
11 |
0.0009 |
| 306 |
CHOLECYSTITIS ACUTE |
5 |
0.0009 |
| 307 |
BLOOD PRESSURE SYSTOLIC DECREASED |
4 |
0.0009 |
| 308 |
BLOOD FIBRINOGEN DECREASED |
1 |
0.0009 |
| 309 |
BLOODY DISCHARGE |
1 |
0.0009 |
| 310 |
JAUNDICE CHOLESTATIC |
3 |
0.0008 |
| 311 |
EOSINOPHIL COUNT DECREASED |
2 |
0.0008 |
| 312 |
BILE DUCT STENOSIS |
1 |
0.0008 |
| 313 |
NEOPLASM PROGRESSION |
29 |
0.0008 |
| 314 |
WEIGHT ABNORMAL |
2 |
0.0008 |
| 315 |
CYTOPENIA |
10 |
0.0008 |
| 316 |
GENERALISED OEDEMA |
10 |
0.0008 |
| 317 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
20 |
0.0008 |
| 318 |
MYELOSUPPRESSION |
29 |
0.0008 |
| 319 |
EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED |
1 |
0.0008 |
| 320 |
BRONCHIAL SECRETION RETENTION |
1 |
0.0008 |
| 321 |
NEUTROPHIL COUNT DECREASED |
32 |
0.0008 |
| 322 |
ADENOCARCINOMA PANCREAS |
1 |
0.0008 |
| 323 |
DRUG CLEARANCE DECREASED |
1 |
0.0008 |
| 324 |
ENCEPHALITIS AUTOIMMUNE |
1 |
0.0008 |
| 325 |
HEPATIC ENCEPHALOPATHY |
7 |
0.0007 |
| 326 |
WEIGHT BEARING DIFFICULTY |
2 |
0.0007 |
| 327 |
WRONG PRODUCT ADMINISTERED |
5 |
0.0007 |
| 328 |
CORNEAL OPACITY |
1 |
0.0007 |
| 329 |
CLONUS |
2 |
0.0007 |
| 330 |
ULCERATIVE KERATITIS |
2 |
0.0007 |
| 331 |
RED BLOOD CELL COUNT INCREASED |
2 |
0.0007 |
| 332 |
CHOLECYSTITIS INFECTIVE |
2 |
0.0007 |
| 333 |
BODY TEMPERATURE DECREASED |
7 |
0.0007 |
| 334 |
BLOOD BILIRUBIN INCREASED |
19 |
0.0007 |
| 335 |
PANCREATIC CARCINOMA METASTATIC |
2 |
0.0007 |
| 336 |
PRODUCT SUPPLY ISSUE |
5 |
0.0007 |
| 337 |
PARAPLEGIA |
2 |
0.0007 |
| 338 |
ESCHERICHIA SEPSIS |
2 |
0.0007 |
| 339 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
16 |
0.0007 |
| 340 |
WRONG PATIENT RECEIVED PRODUCT |
2 |
0.0007 |
| 341 |
GROIN PAIN |
6 |
0.0007 |
| 342 |
BILIARY DILATATION |
1 |
0.0007 |
| 343 |
TOOTH DISCOLOURATION |
2 |
0.0007 |
| 344 |
COCCYDYNIA |
1 |
0.0007 |
| 345 |
CHOLECYSTITIS |
8 |
0.0007 |
| 346 |
VASCULAR DEVICE INFECTION |
3 |
0.0007 |
| 347 |
ASPARTATE AMINOTRANSFERASE ABNORMAL |
1 |
0.0007 |
| 348 |
FIBROSIS |
2 |
0.0006 |
| 349 |
RENAL FUNCTION TEST ABNORMAL |
3 |
0.0006 |
| 350 |
RENAL IMPAIRMENT |
54 |
0.0006 |
| 351 |
INFUSION SITE EXTRAVASATION |
4 |
0.0006 |
| 352 |
ELECTROCARDIOGRAM T WAVE ABNORMAL |
1 |
0.0006 |
| 353 |
TRICUSPID VALVE INCOMPETENCE |
5 |
0.0006 |
| 354 |
BILE DUCT STONE |
2 |
0.0006 |
| 355 |
WHITE BLOOD CELL COUNT ABNORMAL |
4 |
0.0006 |
| 356 |
INTESTINAL PERFORATION |
7 |
0.0006 |
| 357 |
MOUTH ULCERATION |
13 |
0.0006 |
| 358 |
PANCREATIC DISORDER |
3 |
0.0006 |
| 359 |
LIVER DISORDER |
27 |
0.0006 |
| 360 |
MUCOUS STOOLS |
3 |
0.0006 |
| 361 |
ABDOMINAL TENDERNESS |
3 |
0.0006 |
| 362 |
PEPTIC ULCER |
2 |
0.0006 |
| 363 |
ANXIETY DISORDER |
2 |
0.0006 |
| 364 |
ABDOMINAL PAIN |
137 |
0.0006 |
| 365 |
ENTERITIS INFECTIOUS |
1 |
0.0006 |
| 366 |
FEMORAL NECK FRACTURE |
3 |
0.0006 |
| 367 |
MUSCULOSKELETAL CHEST PAIN |
9 |
0.0006 |
| 368 |
APLASIA PURE RED CELL |
2 |
0.0006 |
| 369 |
FLUSHING |
59 |
0.0006 |
| 370 |
RESPIRATION ABNORMAL |
4 |
0.0006 |
| 371 |
ACUTE SINUSITIS |
1 |
0.0006 |
| 372 |
BLOOD CREATININE ABNORMAL |
2 |
0.0006 |
| 373 |
HYPERREFLEXIA |
2 |
0.0006 |
| 374 |
WHITE BLOOD CELL COUNT DECREASED |
62 |
0.0006 |
| 375 |
BURNS SECOND DEGREE |
1 |
0.0006 |
| 376 |
INCONTINENCE |
6 |
0.0006 |
| 377 |
BLOOD CREATININE INCREASED |
37 |
0.0006 |
| 378 |
NEUTROPENIC SEPSIS |
4 |
0.0006 |
| 379 |
JAUNDICE |
15 |
0.0006 |
| 380 |
HAEMOGLOBIN DECREASED |
57 |
0.0006 |
| 381 |
CEREBRAL VENOUS THROMBOSIS |
1 |
0.0006 |
| 382 |
FAECES SOFT |
4 |
0.0005 |
| 383 |
OESOPHAGITIS |
6 |
0.0005 |
| 384 |
THROMBOCYTOSIS |
2 |
0.0005 |
| 385 |
BODY TEMPERATURE ABNORMAL |
1 |
0.0005 |
| 386 |
LEUKOPENIA |
27 |
0.0005 |
| 387 |
CARDIAC DYSFUNCTION |
2 |
0.0005 |
| 388 |
PLATELET COUNT INCREASED |
7 |
0.0005 |
| 389 |
MALNUTRITION |
6 |
0.0005 |
| 390 |
HEPATIC FUNCTION ABNORMAL |
20 |
0.0005 |
| 391 |
PULMONARY ALVEOLAR HAEMORRHAGE |
3 |
0.0005 |
| 392 |
BLOOD CALCIUM DECREASED |
6 |
0.0005 |
| 393 |
ANAEMIA |
100 |
0.0005 |
| 394 |
QUALITY OF LIFE DECREASED |
7 |
0.0005 |
| 395 |
DEVICE RELATED INFECTION |
8 |
0.0005 |
| 396 |
ELECTROLYTE IMBALANCE |
6 |
0.0005 |
| 397 |
EARLY SATIETY |
1 |
0.0005 |
| 398 |
HYPOVOLAEMIA |
3 |
0.0005 |
| 399 |
ADRENOCORTICAL INSUFFICIENCY ACUTE |
1 |
0.0005 |
| 400 |
DEATH |
441 |
0.0005 |
| 401 |
APLASIA |
1 |
0.0005 |
| 402 |
PROSTATOMEGALY |
2 |
0.0005 |
| 403 |
DECREASED INTEREST |
3 |
0.0005 |
| 404 |
DECREASED APPETITE |
118 |
0.0005 |
| 405 |
GLUCOSE TOLERANCE IMPAIRED |
3 |
0.0005 |
| 406 |
LETHARGY |
29 |
0.0005 |
| 407 |
AZOTAEMIA |
2 |
0.0005 |
| 408 |
BLOOD POTASSIUM DECREASED |
15 |
0.0005 |
| 409 |
RECURRENT CANCER |
2 |
0.0005 |
| 410 |
AKINESIA |
1 |
0.0005 |
| 411 |
ASPARTATE AMINOTRANSFERASE INCREASED |
25 |
0.0005 |
| 412 |
CD4 LYMPHOCYTES DECREASED |
1 |
0.0005 |
| 413 |
PROCTALGIA |
3 |
0.0005 |
| 414 |
HAEMOGLOBIN ABNORMAL |
3 |
0.0005 |
| 415 |
AMYOTROPHIC LATERAL SCLEROSIS |
1 |
0.0005 |
| 416 |
HORDEOLUM |
2 |
0.0005 |
| 417 |
FAECES DISCOLOURED |
10 |
0.0005 |
| 418 |
TONGUE DISCOLOURATION |
2 |
0.0005 |
| 419 |
DIVERTICULUM INTESTINAL |
2 |
0.0005 |
| 420 |
BIPOLAR I DISORDER |
1 |
0.0005 |
| 421 |
VULVOVAGINAL DISCOMFORT |
2 |
0.0005 |
| 422 |
THERAPY PARTIAL RESPONDER |
7 |
0.0004 |
| 423 |
NEPHROPATHY TOXIC |
5 |
0.0004 |
| 424 |
URINARY TRACT DISORDER |
2 |
0.0004 |
| 425 |
FEEDING DISORDER |
9 |
0.0004 |
| 426 |
ULCER HAEMORRHAGE |
3 |
0.0004 |
| 427 |
BLOOD LOSS ANAEMIA |
1 |
0.0004 |
| 428 |
CHRONIC MYELOID LEUKAEMIA |
2 |
0.0004 |
| 429 |
MASS |
6 |
0.0004 |
| 430 |
BILIRUBIN CONJUGATED INCREASED |
1 |
0.0004 |
| 431 |
BLOOD SODIUM DECREASED |
8 |
0.0004 |
| 432 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
12 |
0.0004 |
| 433 |
CARDIAC TAMPONADE |
2 |
0.0004 |
| 434 |
HYPOVOLAEMIC SHOCK |
2 |
0.0004 |
| 435 |
SUBCUTANEOUS ABSCESS |
2 |
0.0004 |
| 436 |
LIVER FUNCTION TEST ABNORMAL |
12 |
0.0004 |
| 437 |
KIDNEY INFECTION |
8 |
0.0004 |
| 438 |
INFLAMMATORY MARKER INCREASED |
2 |
0.0004 |
| 439 |
HEPATIC ENZYME ABNORMAL |
2 |
0.0004 |
| 440 |
HYPERAMMONAEMIA |
2 |
0.0004 |
| 441 |
FLUID INTAKE REDUCED |
2 |
0.0004 |
| 442 |
LACRIMATION INCREASED |
12 |
0.0004 |
| 443 |
EMPHYSEMA |
4 |
0.0004 |
| 444 |
SEPSIS |
44 |
0.0004 |
| 445 |
PATHOLOGICAL FRACTURE |
2 |
0.0004 |
| 446 |
BONE MARROW FAILURE |
8 |
0.0004 |
| 447 |
BOWEL MOVEMENT IRREGULARITY |
3 |
0.0004 |
| 448 |
HYPERGLYCAEMIA |
14 |
0.0004 |
| 449 |
PETECHIAE |
4 |
0.0004 |
| 450 |
MALABSORPTION |
2 |
0.0004 |
| 451 |
RENAL CYST |
3 |
0.0004 |
| 452 |
ANORECTAL DISCOMFORT |
2 |
0.0004 |
| 453 |
BLOOD DISORDER |
3 |
0.0004 |
| 454 |
LIVER FUNCTION TEST INCREASED |
8 |
0.0004 |
| 455 |
OVERWEIGHT |
2 |
0.0004 |
| 456 |
ANAL ABSCESS |
2 |
0.0004 |
| 457 |
BLOOD SODIUM INCREASED |
1 |
0.0004 |
| 458 |
DECUBITUS ULCER |
3 |
0.0004 |
| 459 |
CHOLESTASIS |
7 |
0.0004 |
| 460 |
ERUCTATION |
7 |
0.0004 |
| 461 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
8 |
0.0004 |
| 462 |
NEUTROPENIA |
49 |
0.0004 |
| 463 |
PRODUCT LEAKAGE |
2 |
0.0004 |
| 464 |
EJACULATION DISORDER |
1 |
0.0004 |
| 465 |
DYSPNOEA AT REST |
1 |
0.0003 |
| 466 |
BILIARY COLIC |
1 |
0.0003 |
| 467 |
BLOOD PARATHYROID HORMONE INCREASED |
1 |
0.0003 |
| 468 |
URINE OUTPUT DECREASED |
3 |
0.0003 |
| 469 |
NAIL DISORDER |
3 |
0.0003 |
| 470 |
INTENTIONAL PRODUCT USE ISSUE |
30 |
0.0003 |
| 471 |
BLOOD CALCIUM INCREASED |
3 |
0.0003 |
| 472 |
HIP FRACTURE |
11 |
0.0003 |
| 473 |
SPINAL PAIN |
4 |
0.0003 |
| 474 |
PURPURA |
3 |
0.0003 |
| 475 |
LYMPHADENOPATHY |
12 |
0.0003 |
| 476 |
PERITONITIS |
7 |
0.0003 |
| 477 |
SYMPTOM RECURRENCE |
2 |
0.0003 |
| 478 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
60 |
0.0003 |
| 479 |
MALAISE |
146 |
0.0003 |
| 480 |
CEREBROVASCULAR DISORDER |
1 |
0.0003 |
| 481 |
CENTRAL VENOUS CATHETERISATION |
1 |
0.0003 |
| 482 |
GASTROINTESTINAL CARCINOMA |
3 |
0.0003 |
| 483 |
MOOD ALTERED |
9 |
0.0003 |
| 484 |
EMBOLISM VENOUS |
1 |
0.0003 |
| 485 |
NOCTURIA |
4 |
0.0003 |
| 486 |
INGUINAL HERNIA |
2 |
0.0003 |
| 487 |
DIABETIC FOOT |
1 |
0.0003 |
| 488 |
BRAIN NEOPLASM |
3 |
0.0003 |
| 489 |
DUODENITIS |
1 |
0.0003 |
| 490 |
BLOOD GLUCOSE ABNORMAL |
6 |
0.0003 |
| 491 |
HYPERCALCAEMIA |
4 |
0.0003 |
| 492 |
PIGMENTATION DISORDER |
2 |
0.0003 |
| 493 |
NASAL DRYNESS |
2 |
0.0003 |
| 494 |
ABDOMINAL ADHESIONS |
1 |
0.0003 |
| 495 |
HAEMATEMESIS |
8 |
0.0003 |
| 496 |
STOMATITIS |
19 |
0.0003 |
| 497 |
HEART RATE DECREASED |
11 |
0.0003 |
| 498 |
WEIGHT DECREASED |
87 |
0.0003 |
| 499 |
CUSHINGOID |
1 |
0.0003 |
| 500 |
GASTROINTESTINAL HAEMORRHAGE |
26 |
0.0003 |
| 501 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
4 |
0.0003 |
| 502 |
ALANINE AMINOTRANSFERASE INCREASED |
19 |
0.0003 |
| 503 |
INCOHERENT |
2 |
0.0003 |
| 504 |
BLOOD POTASSIUM INCREASED |
5 |
0.0003 |
| 505 |
VITAMIN D DEFICIENCY |
3 |
0.0003 |
| 506 |
RENAL TUBULAR NECROSIS |
3 |
0.0003 |
| 507 |
HYPOKALAEMIA |
14 |
0.0003 |
| 508 |
PERICARDIAL EFFUSION |
7 |
0.0003 |
| 509 |
CORONAVIRUS INFECTION |
2 |
0.0003 |
| 510 |
ARTERIOSCLEROSIS CORONARY ARTERY |
2 |
0.0003 |
| 511 |
POST-TRAUMATIC STRESS DISORDER |
2 |
0.0003 |
| 512 |
NAUSEA |
236 |
0.0003 |
| 513 |
TOXIC SKIN ERUPTION |
3 |
0.0003 |
| 514 |
BREAST MASS |
2 |
0.0003 |
| 515 |
PRODUCT ADMINISTRATION ERROR |
6 |
0.0003 |
| 516 |
PLEURAL EFFUSION |
18 |
0.0003 |
| 517 |
PNEUMONITIS |
8 |
0.0003 |
| 518 |
ABNORMAL LOSS OF WEIGHT |
2 |
0.0003 |
| 519 |
DIARRHOEA |
189 |
0.0003 |
| 520 |
INFARCTION |
2 |
0.0003 |
| 521 |
POOR VENOUS ACCESS |
3 |
0.0003 |
| 522 |
CHRONIC KIDNEY DISEASE |
22 |
0.0003 |
| 523 |
LYMPHOEDEMA |
2 |
0.0003 |
| 524 |
TENDERNESS |
3 |
0.0003 |
| 525 |
HYPOMAGNESAEMIA |
4 |
0.0003 |
| 526 |
ORTHOSTATIC HYPOTENSION |
5 |
0.0003 |
| 527 |
HYPERKALAEMIA |
10 |
0.0003 |
| 528 |
EATING DISORDER |
6 |
0.0003 |
| 529 |
VOMITING |
132 |
0.0003 |
| 530 |
PELVIC PAIN |
5 |
0.0003 |
| 531 |
CHOLELITHIASIS |
9 |
0.0003 |
| 532 |
CUTANEOUS VASCULITIS |
1 |
0.0003 |
| 533 |
HEPATITIS |
7 |
0.0003 |
| 534 |
BLOOD PHOSPHORUS DECREASED |
1 |
0.0003 |
| 535 |
MELAENA |
6 |
0.0003 |
| 536 |
HYPOPHOSPHATAEMIA |
2 |
0.0003 |
| 537 |
URINARY INCONTINENCE |
8 |
0.0003 |
| 538 |
THERAPY NON-RESPONDER |
12 |
0.0003 |
| 539 |
CHRONIC SINUSITIS |
1 |
0.0003 |
| 540 |
AUTOIMMUNE THYROIDITIS |
1 |
0.0003 |
| 541 |
FLATULENCE |
15 |
0.0003 |
| 542 |
CHEMOTHERAPY |
1 |
0.0003 |
| 543 |
ACIDOSIS |
2 |
0.0003 |
| 544 |
LIPASE INCREASED |
2 |
0.0003 |
| 545 |
NEOPLASM |
3 |
0.0003 |
| 546 |
DRY EYE |
13 |
0.0003 |
| 547 |
MENINGIOMA |
4 |
0.0003 |
| 548 |
ORAL HERPES |
5 |
0.0003 |
| 549 |
PRODUCT ADMINISTRATION INTERRUPTED |
2 |
0.0003 |
| 550 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
4 |
0.0003 |
| 551 |
ACCIDENT |
3 |
0.0003 |
| 552 |
ACUTE KIDNEY INJURY |
38 |
0.0002 |
| 553 |
NIGHT SWEATS |
8 |
0.0002 |
| 554 |
FATIGUE |
193 |
0.0002 |
| 555 |
TACHYCARDIA |
22 |
0.0002 |
| 556 |
ABNORMAL FAECES |
2 |
0.0002 |
| 557 |
PRODUCT USE IN UNAPPROVED INDICATION |
60 |
0.0002 |
| 558 |
AORTIC DISSECTION |
1 |
0.0002 |
| 559 |
EOSINOPHIL COUNT INCREASED |
2 |
0.0002 |
| 560 |
SYNCOPE |
24 |
0.0002 |
| 561 |
DYSPNOEA EXERTIONAL |
9 |
0.0002 |
| 562 |
FACE OEDEMA |
4 |
0.0002 |
| 563 |
RENAL DISORDER |
11 |
0.0002 |
| 564 |
AORTIC VALVE INCOMPETENCE |
1 |
0.0002 |
| 565 |
ABSCESS LIMB |
1 |
0.0002 |
| 566 |
FACIAL PARALYSIS |
2 |
0.0002 |
| 567 |
ALOPECIA |
46 |
0.0002 |
| 568 |
CARDIAC MURMUR |
2 |
0.0002 |
| 569 |
ALTERED STATE OF CONSCIOUSNESS |
5 |
0.0002 |
| 570 |
BONE CANCER |
1 |
0.0002 |
| 571 |
NODULE |
3 |
0.0002 |
| 572 |
BLOOD GLUCOSE DECREASED |
11 |
0.0002 |
| 573 |
SPINAL OSTEOARTHRITIS |
2 |
0.0002 |
| 574 |
HYPOXIA |
8 |
0.0002 |
| 575 |
ABDOMINAL ABSCESS |
1 |
0.0002 |
| 576 |
BLOOD CREATINE INCREASED |
1 |
0.0002 |
| 577 |
BLOOD PRESSURE DECREASED |
15 |
0.0002 |
| 578 |
HEPATOTOXICITY |
5 |
0.0002 |
| 579 |
BRAIN NEOPLASM MALIGNANT |
1 |
0.0002 |
| 580 |
PANCREATITIS ACUTE |
5 |
0.0002 |
| 581 |
OEDEMA PERIPHERAL |
27 |
0.0002 |
| 582 |
CHROMATURIA |
5 |
0.0002 |
| 583 |
TACHYPNOEA |
3 |
0.0002 |
| 584 |
ABDOMINAL DISTENSION |
23 |
0.0002 |
| 585 |
BLOOD THYROID STIMULATING HORMONE DECREASED |
1 |
0.0002 |
| 586 |
ACUTE HEPATIC FAILURE |
3 |
0.0002 |
| 587 |
DISEASE COMPLICATION |
1 |
0.0002 |
| 588 |
DYSURIA |
8 |
0.0002 |
| 589 |
HUNGER |
3 |
0.0002 |
| 590 |
NEPHROPATHY |
2 |
0.0002 |
| 591 |
DEVICE OCCLUSION |
3 |
0.0002 |
| 592 |
PHOTOPHOBIA |
4 |
0.0002 |
| 593 |
ARTERIOSCLEROSIS |
2 |
0.0002 |
| 594 |
HYPOCALCAEMIA |
4 |
0.0002 |
| 595 |
SINUS TACHYCARDIA |
3 |
0.0002 |
| 596 |
WHITE BLOOD CELL COUNT INCREASED |
8 |
0.0002 |
| 597 |
LOWER LIMB FRACTURE |
4 |
0.0002 |
| 598 |
ACUTE RESPIRATORY FAILURE |
4 |
0.0002 |
| 599 |
HYPERCHOLESTEROLAEMIA |
2 |
0.0002 |
| 600 |
ATELECTASIS |
2 |
0.0002 |
| 601 |
HERNIA |
4 |
0.0002 |
| 602 |
SEPTIC SHOCK |
9 |
0.0002 |
| 603 |
CONSTIPATION |
45 |
0.0002 |
| 604 |
PYREXIA |
71 |
0.0002 |
| 605 |
DECREASED IMMUNE RESPONSIVENESS |
2 |
0.0002 |
| 606 |
RENAL FAILURE |
27 |
0.0002 |
| 607 |
PULMONARY MASS |
3 |
0.0002 |
| 608 |
HAEMORRHAGE INTRACRANIAL |
3 |
0.0002 |
| 609 |
AGEUSIA |
5 |
0.0002 |
| 610 |
CARDIAC FAILURE |
16 |
0.0002 |
| 611 |
ABDOMINAL PAIN UPPER |
41 |
0.0002 |
| 612 |
CORONARY ARTERY STENOSIS |
1 |
0.0002 |
| 613 |
BLOOD COUNT ABNORMAL |
3 |
0.0002 |
| 614 |
DRUG TOLERANCE |
1 |
0.0002 |
| 615 |
MOTOR DYSFUNCTION |
2 |
0.0002 |
| 616 |
AMMONIA INCREASED |
1 |
0.0002 |
| 617 |
HYPOPHAGIA |
5 |
0.0002 |
| 618 |
ENDOCARDITIS |
1 |
0.0002 |
| 619 |
INITIAL INSOMNIA |
2 |
0.0002 |
| 620 |
ASTHENIA |
73 |
0.0002 |
| 621 |
TEMPERATURE INTOLERANCE |
2 |
0.0002 |
| 622 |
HYPERBILIRUBINAEMIA |
2 |
0.0002 |
| 623 |
HAEMATOMA |
5 |
0.0002 |
| 624 |
TOOTH LOSS |
4 |
0.0002 |
| 625 |
CARDIAC DISORDER |
18 |
0.0002 |
| 626 |
APLASTIC ANAEMIA |
1 |
0.0002 |
| 627 |
HERPES ZOSTER |
11 |
0.0002 |
| 628 |
INJECTION SITE DISCOMFORT |
2 |
0.0002 |
| 629 |
OSTEOARTHRITIS |
8 |
0.0002 |
| 630 |
RENAL PAIN |
2 |
0.0002 |
| 631 |
HYPOTHYROIDISM |
6 |
0.0002 |
| 632 |
RETCHING |
4 |
0.0002 |
| 633 |
DEHYDRATION |
25 |
0.0002 |
| 634 |
ANAL FISTULA |
1 |
0.0002 |
| 635 |
COMPRESSION FRACTURE |
1 |
0.0002 |
| 636 |
ANAL FISSURE |
1 |
0.0002 |
| 637 |
RECTAL HAEMORRHAGE |
8 |
0.0002 |
| 638 |
DECREASED ACTIVITY |
2 |
0.0002 |
| 639 |
DRY MOUTH |
15 |
0.0002 |
| 640 |
DIABETES MELLITUS |
14 |
0.0002 |
| 641 |
CYSTIC FIBROSIS |
1 |
0.0002 |
| 642 |
DIVERTICULITIS |
5 |
0.0002 |
| 643 |
TRANSAMINASES INCREASED |
4 |
0.0002 |
| 644 |
URINARY RETENTION |
6 |
0.0002 |
| 645 |
NEOPLASM MALIGNANT |
12 |
0.0002 |
| 646 |
OBSTRUCTIVE AIRWAYS DISORDER |
2 |
0.0002 |
| 647 |
HYPOTENSION |
36 |
0.0002 |
| 648 |
PLASMA CELL MYELOMA |
7 |
0.0002 |
| 649 |
ORAL PAIN |
4 |
0.0002 |
| 650 |
CELLULITIS |
9 |
0.0002 |
| 651 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
3 |
0.0002 |
| 652 |
ACUTE PULMONARY OEDEMA |
1 |
0.0002 |
| 653 |
MITRAL VALVE INCOMPETENCE |
2 |
0.0002 |
| 654 |
BACK PAIN |
41 |
0.0002 |
| 655 |
CIRCULATORY COLLAPSE |
3 |
0.0002 |
| 656 |
MYOCARDIAL ISCHAEMIA |
2 |
0.0002 |
| 657 |
SCAR |
3 |
0.0002 |
| 658 |
GASTRIC HAEMORRHAGE |
2 |
0.0002 |
| 659 |
PANCREATIC CARCINOMA |
5 |
0.0002 |
| 660 |
DELIRIUM |
6 |
0.0002 |
| 661 |
MUSCULOSKELETAL PAIN |
9 |
0.0002 |
| 662 |
NEEDLE ISSUE |
5 |
0.0002 |
| 663 |
VASCULITIS |
2 |
0.0002 |
| 664 |
BLOOD GLUCOSE INCREASED |
32 |
0.0002 |
| 665 |
BACTERAEMIA |
2 |
0.0002 |
| 666 |
CEREBRAL HAEMORRHAGE |
6 |
0.0002 |
| 667 |
ROAD TRAFFIC ACCIDENT |
7 |
0.0002 |
| 668 |
GOUT |
3 |
0.0002 |
| 669 |
CONTUSION |
16 |
0.0002 |
| 670 |
OEDEMA |
9 |
0.0002 |
| 671 |
HEPATITIS C |
2 |
0.0002 |
| 672 |
DRUG INTOLERANCE |
16 |
0.0002 |
| 673 |
APHASIA |
5 |
0.0002 |
| 674 |
LOCALISED INFECTION |
4 |
0.0002 |
| 675 |
C-REACTIVE PROTEIN INCREASED |
6 |
0.0002 |
| 676 |
LOSS OF CONSCIOUSNESS |
21 |
0.0002 |
| 677 |
LIVER INJURY |
4 |
0.0002 |
| 678 |
NECK PAIN |
9 |
0.0002 |
| 679 |
SECRETION DISCHARGE |
2 |
0.0002 |
| 680 |
MUSCLE ATROPHY |
2 |
0.0002 |
| 681 |
OFF LABEL USE |
137 |
0.0002 |
| 682 |
METABOLIC ACIDOSIS |
5 |
0.0002 |
| 683 |
PULMONARY OEDEMA |
7 |
0.0002 |
| 684 |
C-REACTIVE PROTEIN ABNORMAL |
1 |
0.0002 |
| 685 |
HYPERTENSION |
33 |
0.0002 |
| 686 |
ERECTILE DYSFUNCTION |
4 |
0.0002 |
| 687 |
INFUSION SITE PAIN |
2 |
0.0002 |
| 688 |
ABDOMINAL DISCOMFORT |
26 |
0.0002 |
| 689 |
UNRESPONSIVE TO STIMULI |
4 |
0.0002 |
| 690 |
LACTIC ACIDOSIS |
5 |
0.0002 |
| 691 |
EAR PAIN |
3 |
0.0002 |
| 692 |
ATRIAL FIBRILLATION |
15 |
0.0002 |
| 693 |
HAEMORRHOIDS |
3 |
0.0002 |
| 694 |
BONE PAIN |
9 |
0.0002 |
| 695 |
ORAL CANDIDIASIS |
2 |
0.0002 |
| 696 |
PULMONARY CONGESTION |
2 |
0.0002 |
| 697 |
DISORIENTATION |
6 |
0.0002 |
| 698 |
APPETITE DISORDER |
1 |
0.0002 |
| 699 |
AGITATION |
11 |
0.0001 |
| 700 |
BRONCHIECTASIS |
1 |
0.0001 |
| 701 |
TASTE DISORDER |
3 |
0.0001 |
| 702 |
BODY TEMPERATURE INCREASED |
3 |
0.0001 |
| 703 |
HAEMATURIA |
5 |
0.0001 |
| 704 |
CENTRAL NERVOUS SYSTEM LESION |
2 |
0.0001 |
| 705 |
ORAL DISCOMFORT |
2 |
0.0001 |
| 706 |
FEELING COLD |
4 |
0.0001 |
| 707 |
APHONIA |
2 |
0.0001 |
| 708 |
DEFAECATION URGENCY |
1 |
0.0001 |
| 709 |
OXYGEN SATURATION DECREASED |
8 |
0.0001 |
| 710 |
HYPONATRAEMIA |
8 |
0.0001 |
| 711 |
SKIN REACTION |
2 |
0.0001 |
| 712 |
DUODENAL ULCER |
1 |
0.0001 |
| 713 |
SEASONAL ALLERGY |
2 |
0.0001 |
| 714 |
HEPATOCELLULAR INJURY |
2 |
0.0001 |
| 715 |
DIVERTICULUM |
1 |
0.0001 |
| 716 |
PARALYSIS |
2 |
0.0001 |
| 717 |
HYPERSOMNIA |
4 |
0.0001 |
| 718 |
CARDIOGENIC SHOCK |
2 |
0.0001 |
| 719 |
ACCIDENTAL UNDERDOSE |
2 |
0.0001 |
| 720 |
DEEP VEIN THROMBOSIS |
9 |
0.0001 |
| 721 |
INFECTION |
20 |
0.0001 |
| 722 |
HYPERTHYROIDISM |
2 |
0.0001 |
| 723 |
DERMATITIS BULLOUS |
1 |
0.0001 |
| 724 |
FLUID OVERLOAD |
2 |
0.0001 |
| 725 |
PERIPHERAL SWELLING |
21 |
0.0001 |
| 726 |
INJECTION SITE MASS |
5 |
0.0001 |
| 727 |
URINARY TRACT INFECTION |
23 |
0.0001 |
| 728 |
CARDIAC ARREST |
11 |
0.0001 |
| 729 |
HOT FLUSH |
10 |
0.0001 |
| 730 |
BRADYCARDIA |
7 |
0.0001 |
| 731 |
LOWER RESPIRATORY TRACT INFECTION |
6 |
0.0001 |
| 732 |
AORTIC ANEURYSM |
1 |
0.0001 |
| 733 |
HEART RATE INCREASED |
13 |
0.0001 |
| 734 |
NEPHROLITHIASIS |
6 |
0.0001 |
| 735 |
SHOCK |
3 |
0.0001 |
| 736 |
LYMPHOMA |
2 |
0.0001 |
| 737 |
TENDONITIS |
2 |
0.0001 |
| 738 |
CONCUSSION |
1 |
0.0001 |
| 739 |
RASH PRURITIC |
7 |
0.0001 |
| 740 |
ELECTROCARDIOGRAM ABNORMAL |
1 |
0.0001 |
| 741 |
DYSPNOEA |
72 |
0.0001 |
| 742 |
PAIN |
78 |
0.0001 |
| 743 |
ARRHYTHMIA |
6 |
0.0001 |
| 744 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
9 |
0.0001 |
| 745 |
DISEASE RECURRENCE |
6 |
0.0001 |
| 746 |
PNEUMOTHORAX |
2 |
0.0001 |
| 747 |
INFLUENZA |
14 |
0.0001 |
| 748 |
OBESITY |
2 |
0.0001 |
| 749 |
ATRIAL FLUTTER |
1 |
0.0001 |
| 750 |
PRESYNCOPE |
3 |
0.0001 |
| 751 |
DYSPEPSIA |
12 |
0.0001 |
| 752 |
CONDITION AGGRAVATED |
37 |
0.0001 |
| 753 |
GENERALISED TONIC-CLONIC SEIZURE |
2 |
0.0001 |
| 754 |
EMBOLISM |
1 |
0.0001 |
| 755 |
VIRAL INFECTION |
4 |
0.0001 |
| 756 |
PNEUMONIA ASPIRATION |
3 |
0.0001 |
| 757 |
SKIN DISORDER |
4 |
0.0001 |
| 758 |
GAIT INABILITY |
4 |
0.0001 |
| 759 |
CARDIO-RESPIRATORY ARREST |
5 |
0.0001 |
| 760 |
TYPE 2 DIABETES MELLITUS |
4 |
0.0001 |
| 761 |
ABDOMINAL PAIN LOWER |
3 |
0.0001 |
| 762 |
CANDIDA INFECTION |
2 |
0.0001 |
| 763 |
HEMIPARESIS |
2 |
0.0001 |
| 764 |
CONFUSIONAL STATE |
19 |
0.0001 |
| 765 |
HEPATIC ENZYME INCREASED |
8 |
0.0001 |
| 766 |
BLOOD MAGNESIUM DECREASED |
1 |
0.0001 |
| 767 |
MUCOSAL INFLAMMATION |
3 |
0.0001 |
| 768 |
GASTRITIS |
3 |
0.0001 |
| 769 |
COLD SWEAT |
2 |
0.0001 |
| 770 |
HEAD DISCOMFORT |
2 |
0.0001 |
| 771 |
CARDIOTOXICITY |
1 |
0.0001 |
| 772 |
THROMBOSIS |
9 |
0.0001 |
| 773 |
GASTROINTESTINAL DISORDER |
10 |
0.0001 |
| 774 |
ANAL INCONTINENCE |
1 |
0.0001 |
| 775 |
FREQUENT BOWEL MOVEMENTS |
3 |
0.0001 |
| 776 |
GASTROENTERITIS VIRAL |
2 |
0.0001 |
| 777 |
PALLOR |
3 |
0.0001 |
| 778 |
SKIN LESION |
3 |
0.0001 |
| 779 |
HAEMATOCHEZIA |
6 |
0.0001 |
| 780 |
PROCEDURAL PAIN |
3 |
0.0001 |
| 781 |
OROPHARYNGEAL PAIN |
10 |
0.0001 |
| 782 |
MENTAL STATUS CHANGES |
3 |
0.0001 |
| 783 |
SWELLING FACE |
7 |
0.0001 |
| 784 |
DEMENTIA |
3 |
0.0001 |
| 785 |
COGNITIVE DISORDER |
5 |
0.0001 |
| 786 |
DIARRHOEA HAEMORRHAGIC |
1 |
0.0001 |
| 787 |
HEPATIC CIRRHOSIS |
2 |
0.0001 |
| 788 |
FRACTURE |
2 |
0.0001 |
| 789 |
COLITIS |
4 |
0.0001 |
| 790 |
FOOT FRACTURE |
2 |
0.0001 |
| 791 |
BLOOD URINE PRESENT |
2 |
0.0001 |
| 792 |
GASTRIC ULCER |
2 |
0.0001 |
| 793 |
PULMONARY EMBOLISM |
10 |
0.0001 |
| 794 |
INTERNATIONAL NORMALISED RATIO INCREASED |
3 |
0.0001 |
| 795 |
MUSCULOSKELETAL DISORDER |
2 |
0.0001 |
| 796 |
PNEUMONIA |
34 |
0.0001 |
| 797 |
SLEEP APNOEA SYNDROME |
2 |
0.0001 |
| 798 |
PRODUCTIVE COUGH |
5 |
0.0001 |
| 799 |
BLOOD PRESSURE INCREASED |
16 |
0.0001 |
| 800 |
DIZZINESS POSTURAL |
1 |
0.0001 |
| 801 |
DYSSTASIA |
3 |
0.0001 |
| 802 |
FALL |
34 |
0.0001 |
| 803 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
4 |
0.0001 |
| 804 |
UPPER LIMB FRACTURE |
2 |
0.0001 |
| 805 |
INJURY |
7 |
0.0001 |
| 806 |
MYOCARDIAL INFARCTION |
17 |
0.0001 |
| 807 |
EAR DISCOMFORT |
1 |
0.0001 |
| 808 |
RIB FRACTURE |
2 |
0.0001 |
| 809 |
INFLAMMATION |
5 |
0.0001 |
| 810 |
HAEMORRHAGE |
10 |
0.0001 |
| 811 |
PANCREATITIS |
5 |
0.0001 |
| 812 |
CHILLS |
11 |
0.0001 |
| 813 |
BACK INJURY |
1 |
0.0001 |
| 814 |
INTERVERTEBRAL DISC PROTRUSION |
2 |
0.0001 |
| 815 |
BLOOD GLUCOSE FLUCTUATION |
1 |
0.0001 |
| 816 |
DENTAL CARIES |
1 |
0.0001 |
| 817 |
DIZZINESS |
45 |
0.0001 |
| 818 |
LIP SWELLING |
3 |
0.0001 |
| 819 |
HEART RATE IRREGULAR |
2 |
0.0001 |
| 820 |
MUSCULAR WEAKNESS |
10 |
0.0001 |
| 821 |
CHOLECYSTECTOMY |
1 |
0.0001 |
| 822 |
RASH |
38 |
0.0001 |
| 823 |
CHEST PAIN |
16 |
0.0001 |
| 824 |
RASH MACULAR |
3 |
0.0001 |
| 825 |
DYSPHONIA |
5 |
0.0001 |
| 826 |
PALPITATIONS |
10 |
0.0001 |
| 827 |
BLOOD IRON DECREASED |
1 |
0.0001 |
| 828 |
ATAXIA |
1 |
0.0001 |
| 829 |
DEPRESSION |
19 |
0.0001 |
| 830 |
CEREBROVASCULAR ACCIDENT |
14 |
0.0001 |
| 831 |
INTERSTITIAL LUNG DISEASE |
4 |
0.0001 |
| 832 |
MENTAL IMPAIRMENT |
2 |
0.0001 |
| 833 |
UNDERDOSE |
6 |
0.0001 |
| 834 |
COUGH |
23 |
0.0001 |
| 835 |
DISCOMFORT |
5 |
0.0001 |
| 836 |
CEREBRAL INFARCTION |
2 |
0.0001 |
| 837 |
LUNG DISORDER |
4 |
0.0001 |
| 838 |
ENCEPHALOPATHY |
2 |
0.0001 |
| 839 |
CARDIOMEGALY |
1 |
0.0001 |
| 840 |
DRUG DEPENDENCE |
13 |
0.0001 |
| 841 |
OSTEONECROSIS OF JAW |
2 |
0.0001 |
| 842 |
EPISTAXIS |
6 |
0.0001 |
| 843 |
DYSARTHRIA |
3 |
0.0001 |
| 844 |
HALLUCINATION |
6 |
0.0001 |
| 845 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
2 |
0.0001 |
| 846 |
SEIZURE |
9 |
0.0001 |
| 847 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
4 |
0.0001 |
| 848 |
MYALGIA |
13 |
0.0001 |
| 849 |
NASOPHARYNGITIS |
14 |
0.0001 |
| 850 |
INJECTION SITE HAEMORRHAGE |
6 |
0.0001 |
| 851 |
PROSTATE CANCER |
6 |
0.0001 |
| 852 |
LIMB INJURY |
2 |
0.0001 |
| 853 |
BLINDNESS |
3 |
0.0001 |
| 854 |
GAIT DISTURBANCE |
14 |
0.0001 |
| 855 |
LUNG NEOPLASM MALIGNANT |
3 |
0.0001 |
| 856 |
POLLAKIURIA |
3 |
0.0001 |
| 857 |
HAEMOPTYSIS |
2 |
0.0001 |
| 858 |
COORDINATION ABNORMAL |
1 |
0.0001 |
| 859 |
PAIN IN EXTREMITY |
21 |
0.0001 |
| 860 |
BLISTER |
4 |
0.0001 |
| 861 |
BLINDNESS UNILATERAL |
1 |
0.0001 |
| 862 |
BRONCHOSPASM |
1 |
0.0001 |
| 863 |
HYPERHIDROSIS |
9 |
0.0001 |
| 864 |
ANGINA PECTORIS |
2 |
0.0001 |
| 865 |
MOBILITY DECREASED |
5 |
0.0001 |
| 866 |
ANOSMIA |
1 |
0.0001 |
| 867 |
MENTAL DISORDER |
3 |
0.0001 |
| 868 |
COMPLICATION ASSOCIATED WITH DEVICE |
1 |
0.0001 |
| 869 |
RESPIRATORY FAILURE |
5 |
0.0001 |
| 870 |
ANGIOEDEMA |
3 |
0.0001 |
| 871 |
CARDIOMYOPATHY |
1 |
0.0001 |
| 872 |
DRUG EFFECT LESS THAN EXPECTED |
1 |
0.0001 |
| 873 |
DYSGEUSIA |
5 |
0.0001 |
| 874 |
THERAPEUTIC RESPONSE UNEXPECTED |
3 |
0.0001 |
| 875 |
RESPIRATORY DISORDER |
2 |
0.0001 |
| 876 |
HYPOAESTHESIA |
10 |
0.0001 |
| 877 |
CONTRAINDICATED PRODUCT ADMINISTERED |
2 |
0.0001 |
| 878 |
EPILEPSY |
2 |
0.0001 |
| 879 |
SKIN DISCOLOURATION |
3 |
0.0001 |
| 880 |
ARTHRALGIA |
27 |
0.0001 |
| 881 |
LIMB DISCOMFORT |
2 |
0.0001 |
| 882 |
ANKLE FRACTURE |
1 |
0.0001 |
| 883 |
FEMUR FRACTURE |
2 |
0.0001 |
| 884 |
BRAIN FOG |
1 |
0.0001 |
| 885 |
ANXIETY |
18 |
0.0001 |
| 886 |
OCULAR HYPERAEMIA |
3 |
0.0001 |
| 887 |
HEAD INJURY |
2 |
0.0001 |
| 888 |
CYSTITIS |
2 |
0.0001 |
| 889 |
MOVEMENT DISORDER |
2 |
0.0001 |
| 890 |
RHINORRHOEA |
4 |
0.0001 |
| 891 |
BACK DISORDER |
1 |
0.0001 |
| 892 |
IMPAIRED HEALING |
2 |
0.0001 |
| 893 |
INFLUENZA LIKE ILLNESS |
5 |
0.0001 |
| 894 |
HEADACHE |
38 |
0.0001 |
| 895 |
VISUAL ACUITY REDUCED |
2 |
0.0001 |
| 896 |
TOXICITY TO VARIOUS AGENTS |
10 |
0.0001 |
| 897 |
INJECTION SITE REACTION |
4 |
0.0001 |
| 898 |
SPEECH DISORDER |
3 |
0.0001 |
| 899 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
1 |
0.0001 |
| 900 |
DRUG ERUPTION |
1 |
0.0001 |
| 901 |
END STAGE RENAL DISEASE |
1 |
0.0001 |
| 902 |
RESTLESSNESS |
2 |
0.0001 |
| 903 |
ANAPHYLACTIC REACTION |
3 |
0.0001 |
| 904 |
HYPERSENSITIVITY |
10 |
0.0001 |
| 905 |
AGRANULOCYTOSIS |
1 |
0.0001 |
| 906 |
BREAST CANCER |
5 |
0.0001 |
| 907 |
WEIGHT INCREASED |
12 |
0.0001 |
| 908 |
SWELLING |
5 |
0.0001 |
| 909 |
CHOKING |
1 |
0.0001 |
| 910 |
PRODUCT DOSE OMISSION ISSUE |
15 |
0.0001 |
| 911 |
BLOOD PRESSURE ABNORMAL |
1 |
0.0001 |
| 912 |
CYTOKINE RELEASE SYNDROME |
1 |
0.0000 |
| 913 |
CARDIAC FAILURE CONGESTIVE |
4 |
0.0000 |
| 914 |
GASTROOESOPHAGEAL REFLUX DISEASE |
4 |
0.0000 |
| 915 |
EXTRA DOSE ADMINISTERED |
2 |
0.0000 |
| 916 |
CHEST DISCOMFORT |
5 |
0.0000 |
| 917 |
INSOMNIA |
13 |
0.0000 |
| 918 |
ERYTHEMA |
10 |
0.0000 |
| 919 |
DEVICE LEAKAGE |
2 |
0.0000 |
| 920 |
CLOSTRIDIUM DIFFICILE INFECTION |
1 |
0.0000 |
| 921 |
INJECTION SITE PRURITUS |
3 |
0.0000 |
| 922 |
PRURITUS |
17 |
0.0000 |
| 923 |
MUSCLE SPASMS |
8 |
0.0000 |
| 924 |
TINNITUS |
2 |
0.0000 |
| 925 |
PRODUCT USE ISSUE |
8 |
0.0000 |
| 926 |
DRUG INEFFECTIVE |
56 |
0.0000 |
| 927 |
DYSPHAGIA |
4 |
0.0000 |
| 928 |
RASH ERYTHEMATOUS |
2 |
0.0000 |
| 929 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
2 |
0.0000 |
| 930 |
DIABETIC KETOACIDOSIS |
1 |
0.0000 |
| 931 |
JOINT SWELLING |
5 |
0.0000 |
| 932 |
SOMNOLENCE |
8 |
0.0000 |
| 933 |
CARDIOVASCULAR DISORDER |
1 |
0.0000 |
| 934 |
FLUID RETENTION |
2 |
0.0000 |
| 935 |
INJECTION SITE SWELLING |
3 |
0.0000 |
| 936 |
HOSPITALISATION |
6 |
0.0000 |
| 937 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
1 |
0.0000 |
| 938 |
NERVOUSNESS |
2 |
0.0000 |
| 939 |
DEAFNESS |
1 |
0.0000 |
| 940 |
ECZEMA |
2 |
0.0000 |
| 941 |
ARTHRITIS |
3 |
0.0000 |
| 942 |
DEPRESSED MOOD |
2 |
0.0000 |
| 943 |
DRY SKIN |
5 |
0.0000 |
| 944 |
MEDICATION ERROR |
2 |
0.0000 |
| 945 |
INJECTION SITE PAIN |
11 |
0.0000 |
| 946 |
SKIN EXFOLIATION |
3 |
0.0000 |
| 947 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
1 |
0.0000 |
| 948 |
BALANCE DISORDER |
3 |
0.0000 |
| 949 |
ACUTE MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 950 |
WHEEZING |
2 |
0.0000 |
| 951 |
ADVERSE DRUG REACTION |
3 |
0.0000 |
| 952 |
FEELING ABNORMAL |
8 |
0.0000 |
| 953 |
CORONARY ARTERY DISEASE |
1 |
0.0000 |
| 954 |
THERAPEUTIC RESPONSE DECREASED |
2 |
0.0000 |
| 955 |
EMOTIONAL DISORDER |
1 |
0.0000 |
| 956 |
DRUG-INDUCED LIVER INJURY |
1 |
0.0000 |
| 957 |
NEUROPATHY PERIPHERAL |
3 |
0.0000 |
| 958 |
AMNESIA |
2 |
0.0000 |
| 959 |
INFUSION RELATED REACTION |
2 |
0.0000 |
| 960 |
FEBRILE NEUTROPENIA |
2 |
0.0000 |
| 961 |
TREMOR |
5 |
0.0000 |
| 962 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
1 |
0.0000 |
| 963 |
MEMORY IMPAIRMENT |
4 |
0.0000 |
| 964 |
ACCIDENTAL EXPOSURE TO PRODUCT |
3 |
0.0000 |
| 965 |
BURNING SENSATION |
2 |
0.0000 |
| 966 |
THERAPY INTERRUPTED |
2 |
0.0000 |
| 967 |
BRONCHITIS |
2 |
0.0000 |
| 968 |
ASTHMA |
3 |
0.0000 |
| 969 |
INCORRECT DOSE ADMINISTERED |
6 |
0.0000 |
| 970 |
PARAESTHESIA |
4 |
0.0000 |
| 971 |
DEVICE BREAKAGE |
1 |
0.0000 |
| 972 |
VISUAL IMPAIRMENT |
3 |
0.0000 |
| 973 |
INJECTION SITE ERYTHEMA |
3 |
0.0000 |
| 974 |
TREATMENT FAILURE |
2 |
0.0000 |
| 975 |
COMPLETED SUICIDE |
2 |
0.0000 |
| 976 |
URTICARIA |
4 |
0.0000 |
| 977 |
MATERNAL EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 978 |
VISION BLURRED |
3 |
0.0000 |
| 979 |
BLOOD CHOLESTEROL INCREASED |
1 |
0.0000 |
| 980 |
MIGRAINE |
2 |
0.0000 |
| 981 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 982 |
BLADDER CANCER |
1 |
0.0000 |
| 983 |
DEVICE MALFUNCTION |
1 |
0.0000 |
| 984 |
DRUG INTERACTION |
2 |
0.0000 |
| 985 |
DRUG ABUSE |
1 |
0.0000 |
| 986 |
DEVICE ISSUE |
1 |
0.0000 |
| 987 |
ADVERSE EVENT |
1 |
0.0000 |